Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Ongentys

PharmaCompass

01

Brand Name : Ongentys

Opicapone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Ongentys

arrow
2024 ACI Convention
Not Confirmed

Opicapone

Main Therapeutic Indication : Neurology

Currency : USD

2020 Revenue in Millions : 1

2019 Revenue in Millions : 0

Growth (%) : 100

blank

02

Brand Name : Ongentys

Opicapone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Ongentys

arrow
2024 ACI Convention
Not Confirmed

Opicapone

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 17

2020 Revenue in Millions : 0

Growth (%) : 100

blank

03

Brand Name : Ongentys

Opicapone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Ongentys

arrow
2024 ACI Convention
Not Confirmed

Opicapone

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 8

2020 Revenue in Millions : 1

Growth (%) : 720

blank

04

Brand Name : Ongentys

Opicapone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Ongentys

arrow
2024 ACI Convention
Not Confirmed

Opicapone

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 36

2021 Revenue in Millions : 17

Growth (%) : 114

blank

05

Brand Name : Ongentys

Opicapone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Ongentys

arrow
2024 ACI Convention
Not Confirmed

Opicapone

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 13

2021 Revenue in Millions : 8

Growth (%) : 60

blank

06

Brand Name : Ongentys

Opicapone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Ongentys

arrow
2024 ACI Convention
Not Confirmed

Opicapone

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 41

2022 Revenue in Millions : 36

Growth (%) : 30

blank